Anxiety and depression in menopaused women.
Conditions
Interventions
Intervention 1: Intervention group: will receive one oral capsule containing 250 mg of parsley powder twice daily, at least half an hour after breakfast and after dinner (total daily dose will be 500
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 60 Years
Inclusion criteria
Inclusion criteria: Willingness to participate in the study Having at least primary education Age 45 to 60 years No menstrual bleeding or spotting for at least the past year Mild to moderate symptoms of anxiety and depression based on the Spielberger State-Trait Anxiety Inventory and Beck Depression Inventory
Exclusion criteria
Exclusion criteria: Allergy to parsley Major depression requires specialized treatment People with thoughts of suicide and self-harm Having all known physical disorders and diseases, such as kidney, liver, heart, thyroid, bleeding diseases, malignancies, degenerative and autoimmune diseases Use of antidepressants and tranquilizers in the past 3 months Having a history of stressful events or unfortunate events in the last 6 months, such as the death of a spouse or loved one Having a history of drug and alcohol abuse Simultaneous use of medicinal herbs for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression score on the Beck Depression Inventory. Timepoint: At the beginning of the study and weeks 4 and 8 after the intervention. Method of measurement: The Beck Depression Inventory will be used to measure depression.;Anxiety score on the Spielberger State-Trait Inventory. Timepoint: At the beginning of the study and weeks 4 and 8 after the intervention. Method of measurement: The Spielberger Trait State Inventory will be used to measure anxiety. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParastoo Daemi Mojdehi
Ahvaz University of Medical Sciences
Outcome results
None listed